International

Utilizing Owkin’s expansive data network and cutting-edge AI, this solution optimizes pre-screening for gBRCA mutations in breast cancer directly from digitized H&E pathology slides The solution aims to improve gBRCA...

Mindpeak: Funding strengthens the product development roadmap for AI-powered histopathological assessments, supporting clinical labs and biopharma companies worldwide. HAMBURG, Germany--(BUSINESS WIRE)--Mindpeak, the leader in AI-powered...

From Deciphex on LinkedIn: Big News! 🎉 We’re proud to share that Deciphex has been ranked 8th on LinkedIn’s Top Startups 2024 list for Ireland! This recognition is a testament to our work in advancing digital pathology and...

Gestalt and DataPath: The companies are focused on making an impact on healthcare accessibility SPOKANE, Wash., Sept. 16, 2024 /PRNewswire/ -- Gestalt, a leader in AI-driven digital pathology solutions, is excited to announce its...

Dublin, 16th September 2024 — Deciphex today announced the launch of VICT3R, a groundbreaking initiative aimed at transforming nonclinical drug and chemical safety evaluation. VICT3R is a public-private partnership supported by the...

Nijmegen, the Netherlands – Aiosyn is proud to announce the first results of an independent clinical performance study conducted for its Aiosyn Mitosis Breast solution. This study was performed at Radboud University Medical Center...